Effects of pentylenetetrazole-induced seizures on metabolomic profiles of rat brain

Neurochemistry International

Volumn 56, Issue 2, 2010, Pages 340-344

  Carmody, Stacey ^a   Brennan, Lorraine ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Epilepsy; Metabolomics; PTZ kindling

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; CREATINE; GLYCEROPHOSPHORYLCHOLINE; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; PENTETRAZOLE; PHOSPHORYLCHOLINE; SUCCINIC ACID; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; HIPPOCAMPUS; KINDLING; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SEIZURE;

ANIMALS; BRAIN; CONVULSANTS; DISCRIMINANT ANALYSIS; LEAST-SQUARES ANALYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; SEIZURES;

ANIMALIA; RATTUS;

EID: 77149141400     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.11.004     Document Type: Article

References (32)

1. Alvestad S., Hammer J., Eyjolfsson E., Qu H., Ottersen O.P., Sonnewald U. Limbic structures show altered glial-neuronal metabolism in the chronic phase of kainate induced epilepsy. Neurochem. Res. 2008, 33:257-266.
2. Briellmann R.S., Wellard R.M., Jackson G.D. Seizure-associated abnormalities in epilepsy: evidence from MR Imaging. Epilepsia 2005, 46:760-766.
3. Darbin O., Risso J.J., Carre E., Lonjon M., Naritoku D.K. Metabolic changes in rat striatum following convulsive seizures. Brain Res. 2005, 1050:124-129.
4. Eloqayli H., Dahl C.B., Gotestam K.G., Unsgard G., Hadidi H., Sonnewald U. Pentylenetetrazole decreases metabolic glutamate turnover in rat brain. J. Neurochem. 2003, 85:1200-1207.
5. Eloqayli H., Dahl C.B., Gotestam K.G., Unsgard G., Sonnewald U. Changes of glial-neuronal interaction and metabolism after a subconvulsive dose of pentylenetetrazole. Neurochem. Int. 2004, 45:739-745.
6. Griffin J.L., Cemal C.K., Pook M.A. Defining a metabolic phenotype in the brain of a transgenic mouse model of spinocerebellar ataxia 3. Physiol. Genomics 2004, 16:334-340.
7. Hammen T., Stefan H., Eberhardt K.E., W-Huk B.H., Tomandl B.F. Clinical applications of 1H-MR spectroscopy in the evaluation of epilepsies-what do pathological spectra stand for with regard to current results and what answers do they give to common clinical questions concerning the treatment of epilepsies?. Acta Neurol. Scand. 2003, 108:223-238.
8. Hiremath G.K., Najm I.M. Magnetic resonance spectroscopy in animal models of epilepsy. Epilepsia 2007, 48:47-55.
9. Holopainen I.E. Seizures in the developing brain: cellular and molecular mechanisms of neuronal damage, neurogenesis and cellular reorganization. Neurochem. Int. 2008, 52:935-947.
10. Holtzman D., Meyers R., Khait I., Jensen F. Brain creatine kinase reaction rates and reactant concentrations during seizures in developing rats. Epilepsy Res. 1997, 27:7-11.
11. Holtzman D., Mulkern R., Meyers R., Cook C., Allred E., Khait I., Jensen F., Tsuji M., Laussen P. In vivo phosphocreatine and ATP in piglet cerebral gray and white matter during seizures. Brain Res. 1998, 783:19-27.
12. Lan M.J., McLoughlin G.A., Griffin J.L., Tsang T.M., Huang J.T., Yuan P., Manji H., Holmes E., Bahn S. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol. Psychiatry 2009, 14:269-279.
13. Li Z.P., Zhang X.Y., Lu X., Zhong M.K., Ji Y.H. Dynamic release of amino acid transmitters induced by valproate in PTZ-kindled epileptic rat hippocampus. Neurochem. Int. 2004, 44:263-270.
14. Macdonald R.L., Barker J.L. Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones. Nature 1977, 267:720-721.
15. Macdonald R.L., Barker J.L. Different actions of anticonvulsant and anesthetic barbiturates revealed by use of cultured mammalian neurons. Science 1978, 200:775-777.
16. Mao H., Toufexis D., Wang X., Lacreuse A., Wu S. Changes of metabolite profile in kainic acid induced hippocampal injury in rats measured by HRMAS NMR. Exp. Brain Res. 2007, 183:477-485.
17. Pears M.R., Salek R.M., Palmer D.N., Kay G.W., Mortishire-Smith R.J., Griffin J.L. Metabolomic investigation of CLN6 neuronal ceroid lipofuscinosis in affected South Hampshire sheep. J. Neurosci. Res. 2007, 85:3494-3504.
18. Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:10625-10629.
19. Petroff O.A., Errante L.D., Rothman D.L., Kim J.H., Spencer D.D. Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia 2002, 43:703-710.
20. Petroff O.A., Prichard J.W., Behar K.L., Alger J.R., Shulman R.G. In vivo phosphorus nuclear magnetic resonance spectroscopy in status epilepticus. Ann. Neurol. 1984, 16:169-177.
21. Qu H., Eloqayli H., Sonnewald U. Pentylenetetrazole affects metabolism of astrocytes in culture. J. Neurosci. Res. 2005, 79:48-54.
22. Ross B.D., Bluml S., Cowan R., Danielsen E., Farrow N., Gruetter R. In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys. Chem. 1997, 68:161-172.
23. Sander J.W., Shorvon S.D. Epidemiology of the epilepsies. J. Neurol. Neurosurg. Psychiatry 1996, 61:433-443.
24. Taylor C.P. How do seizures begin? Clues from hippocampal slices. Trends Neurosci. 1988, 11:375-378.
25. Tsai G., Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 1995, 46:531-540.
26. Tsang T.M., Griffin J.L., Haselden J., Fish C., Holmes E. Metabolic characterization of distinct neuroanatomical regions in rats by magic angle spinning 1H nuclear magnetic resonance spectroscopy. Magn. Reson. Med. 2005, 53:1018-1024.
27. Tsang T.M., Woodman B., McLoughlin G.A., Griffin J.L., Tabrizi S.J., Bates G.P., Holmes E. Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy. J. Proteome Res. 2006, 5:483-492.
28. van Gelder N.M. Contributions of basic neurochemistry towards a novel concept of epilepsy. Neurochem. Res. 1987, 12:111-119.
29. Wellard R.M., Briellmann R.S., Prichard J.W., Syngeniotis A., Jackson G.D. Myoinositol abnormalities in temporal lobe epilepsy. Epilepsia 2003, 44:815-821.
30. Wheler G.H., Osborne R.H., Bradford H.F., Davison A.N. Uptake studies of taurine in vivo and its effects on the course of experimental focal epilepsy in rats. Brain Res. 1977, 136:535-542.
31. Young R.S., Osbakken M.D., Briggs R.W., Yagel S.K., Rice D.W., Goldberg S. 31P NMR study of cerebral metabolism during prolonged seizures in the neonatal dog. Ann. Neurol. 1985, 18:14-20.
32. Yudkoff M., Daikhin Y., Nissim I., Horyn O., Lazarow A., Nissim I. Metabolism of brain amino acids following pentylenetetrazole treatment. Epilepsy Res. 2003, 53:151-162.